Author

Katsushi Kumata

National Institutes for Quantum Science and Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:non-human primate· 3 Organism:mouse· 2 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Koki MimuraiD· 4 shared Ming-Rong ZhangiD· 4 shared Takafumi MinamimotoiD· 4 shared Yuji NagaiiD· 4 shared Makoto HiguchiiD· 3 shared Tetsuya SuharaiD· 3 shared Yukiko HoriiD· 3 shared Chie SekiiD· 2 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersNeuroscience

Koki MimuraORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Longitudinal assessment of DREADD expression and efficacy in the monkey brain

Yuji Nagai, Yukiko Hori, Ken-ichi Inoue, Toshiyuki Hirabayashi, Koki Mimura, Kei Oyama, Naohisa Miyakawa, Yuki Hori, Haruhiko Iwaoki, Katsushi Kumata, Ming-Rong Zhang, Masahiko Takada, Makoto Higuchi, Takafumi Minamimoto

This study longitudinally assesses DREADD expression and efficacy in macaque monkeys using PET imaging and functional studies, showing peak expression at 60 days and sustained effects for two years.

eLife · Oct 22, 2025Peer-reviewedNeuroscience

Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases

Hironobu Endo, Maiko Ono, Yuhei Takado, Kiwamu Matsuoka, Manami Takahashi, Kenji Tagai, Yuko Kataoka, Kosei Hirata, Keisuke Takahata, Chie Seki, Naomi Kokubo, Masayuki Fujinaga, Wakana Mori, Yuji Nagai, Koki Mimura, , Makoto Higuchi

This study develops a PET ligand to visualize α-synuclein pathologies in Parkinson's and DLB patients, showing increased signals in affected brain regions.

Neuron · Jun 5, 2024Peer-reviewedNeuroscience

Reduced serotonergic transmission alters sensitivity to cost and reward via 5-HT1A and 5-HT1B receptors in monkeys

Yukiko Hori, Koki Mimura, Yuji Nagai, Yuki Hori, Katsushi Kumata, Ming‐Rong Zhang, Tetsuya Suhara, Makoto Higuchi, Takafumi Minamimoto

This study shows that 5-HT1A and 5-HT1B receptor blockade separately affects motivation by altering sensitivity to cost and reward in monkeys.

bioRxiv · Feb 23, 2023 · PreprintNeuroscience

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

Yuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa, Yukiko Hori, Kei Oyama, Bin Ji, Manami Takahashi, Xi‐Ping Huang, Samuel T. Slocum, Jeffrey F. DiBerto, Yan Xiong, Takuya Urushihata, Toshiyuki Hirabayashi, Atsushi Fujimoto, Koki Mimura, , Takafumi Minamimoto

This paper introduces deschloroclozapine (DCZ), a potent and selective DREADD agonist that rapidly modulates neuronal activity and behavior in mice and monkeys.

Nature Neuroscience · Jul 6, 2020Peer-reviewedNeuroscience